Trinity Biotech (TRIB) Non-Current Assets (2009 - 2025)
Trinity Biotech (TRIB) posted Non-Current Assets of $69.3 million for Q4 2025, up 3.95% sequentially from $66.6 million in Q2 2025, and up 11.42% YoY from $62.2 million in Q4 2024.
Trinity Biotech (TRIB) Non-Current Assets (2009 - 2025) Analysis & Trends
Trinity Biotech has reported Non-Current Assets for 17 years, with the latest figure at $69.3 million in Q4 2025.
- Quarterly Non-Current Assets rose 11.42% year-over-year to $69.3 million in Q4 2025, while the trailing twelve-month figure through Jun 2025 was $66.6 million (up 37.75% YoY) and the FY2025 annual result came in at $69.3 million, up 11.42% from the prior year.
- Non-Current Assets rose to $69.3 million in Q4 2025 per TRIB's latest filing, from $66.6 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $69.3 million in Q4 2025 and troughed at $19.1 million in Q2 2023.
- A 5-year average of $44.9 million and a median of $47.0 million in 2021 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2023 and 2024: Non-Current Assets plunged 61.78% in 2023, then soared 204.82% in 2024.
- Over 5 years, Non-Current Assets stood at $46.2 million in 2021, then retreated by 1.67% to $45.4 million in 2022, then plunged by 55.11% to $20.4 million in 2023, then jumped by 204.82% to $62.2 million in 2024, then climbed by 11.42% to $69.3 million in 2025.
- According to Business Quant data, Non-Current Assets over the past three periods registered $69.3 million, $66.6 million, and $62.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Trinity Biotech | 6.53 Mn | 1.39 Mn | - | 69.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69.26 Mn |
| Jun 30, 2025 | 66.63 Mn |
| Dec 31, 2024 | 62.17 Mn |
| Sep 30, 2024 | 51.37 Mn |
| Jun 30, 2024 | 48.37 Mn |
| Mar 31, 2024 | 44.27 Mn |
| Dec 31, 2023 | 20.39 Mn |
| Sep 30, 2023 | 19.77 Mn |
| Jun 30, 2023 | 19.07 Mn |
| Mar 31, 2023 | 32.90 Mn |
| Dec 31, 2022 | 45.44 Mn |
| Sep 30, 2022 | 48.06 Mn |
| Jun 30, 2022 | 49.90 Mn |
| Mar 31, 2022 | 47.83 Mn |
| Dec 31, 2021 | 46.21 Mn |
| Sep 30, 2021 | 44.53 Mn |
| Jun 30, 2021 | 43.26 Mn |
| Mar 31, 2021 | 48.37 Mn |
| Dec 31, 2020 | 47.10 Mn |
| Sep 30, 2020 | 63.71 Mn |